- CEO
- Hou Iam Cheong
- Full Time Employees
- 156
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Room 101 Zhuhai GD People's Republic of China
- IPO Date
- Jun 30, 2026
- Business
- Guangdong True Health Medical Technology Development Co., Ltd. engages in the research, development, manufacturing, and sale of medical devices and health technology solutions, with ticker 2697.HK listed on the Hong Kong Exchange. The company focuses on intelligent medical hardware, interventional devices, diagnostic equipment, and related healthcare IT platforms, delivering integrated medical technology products and services for hospitals, clinics, and healthcare providers.
Main products and services:
high-precision imaging and diagnostic devices; minimally invasive interventional instruments and consumables; smart hospital equipment and connected health IT platforms; wound care and rehabilitation devices; consumer health tech and telemedicine solutions; sterilization and facility management solutions; medical software, data analytics, and remote monitoring services; research and development services for medical device integration; regulatory and quality assurance support offerings; after-sales service and maintenance contracts; educational and training programs for clinical adoption; firmware and hardware integration kits; modular medical device ecosystems enabling interoperability; customization and OEM/ODM manufacturing for third-party brands.
Geographic and operating footprint:
operates primarily within China with expansion to international markets in Asia-Pacific, Europe, and the Americas; maintains manufacturing facilities in Guangdong province; serves hospitals, clinics, healthcare distributors, and integrators across multiple regions; supports global customers through regional offices, service centers, and authorized distributors.
Founding year and headquarters:
founded in the early 2010s; headquarters located in Guangdong Province, China.
Industry and segments:
active in medical devices and health technology; segments include imaging and diagnostic devices, interventional solutions, smart hospital and IT platforms, consumer health technology, and related services.
Subsidiaries and corporate structure:
structured with a parent holding company and multiple subsidiaries focusing on product development, manufacturing, sales, and after-sales support; maintains affiliations with strategic partners and suppliers to enhance R&D, regulatory, and distribution capabilities.
Latest major changes:
recent partnerships and strategic alliances in the medical device ecosystem; recent funding rounds or acquisitions to bolster product lines and geographic reach; new product launches spanning diagnostic imaging, interventional devices, and smart hospital IT platforms; major strategic shifts toward deeper vertical integration, expanded international distribution, and enhanced regulatory approvals; corporate reorganization or name adjustments within the group to optimize operations; notable operational changes in manufacturing scale, supply chain resilience, and service network expansion within the last 1-2 years.
Additional context:
industry position centers on device innovation, intelligent healthcare hardware, and integrated care solutions; targets hospitals, clinics, and healthcare providers seeking high-quality diagnostic and treatment technologies; geographic operations span China and international markets, with emphasis on regions pursuing digital health and minimally invasive medical care; parent-subsidiary relationships support a broad portfolio across device categories and software platforms.